|
1
|
Kadow T, Sowa G, Vo N and Kang JD:
Molecular basis of intervertebral disc degeneration and
herniations: What are the important translational questions? Clin
Orthop Relat Res. 473:1903–1912. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tang P, Gu JM, Xie ZA, Gu Y, Jie ZW, Huang
KM, Wang JY, Fan SW, Jiang XS and Hu ZJ: Honokiol alleviates the
degeneration of intervertebral disc via suppressing the activation
of TXNIP-NLRP3 inflammasome signal pathway. Free Radic Biol Med.
120:368–379. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Powell MC, Wilson M, Szypryt P, Symonds EM
and Worthington BS: Prevalence of lumbar disc degeneration observed
by magnetic resonance in symptomless women. Lancet. 2:1366–1367.
1986.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hangai M, Kaneoka K, Kuno S, Hinotsu S,
Sakane M, Mamizuka N, Sakai S and Ochiai N: Factors associated with
lumbar intervertebral disc degeneration in the elderly. Spine J.
8:732–740. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liuke M, Solovieva S, Lamminen A, Luoma K,
Leino-Arjas P, Luukkonen R and Riihimäki H: Disc degeneration of
the lumbar spine in relation to overweight. Int J Obes (Lond).
29:903–908. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Oda H, Matsuzaki H, Tokuhashi Y,
Wakabayashi K, Uematsu Y and Iwahashi M: Degeneration of
intervertebral discs due to smoking: Experimental assessment in a
rat-smoking model. J Orthop Sci. 9:135–141. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jhawar BS, Fuchs CS, Colditz GA and
Stampfer MJ: Cardiovascular risk factors for physician-diagnosed
lumbar disc herniation. Spine J. 6:684–691. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kauppila LI: Atherosclerosis and disc
degeneration/low-back pain-a systematic review. Eur J Vasc Endovasc
Surg. 37:661–670. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Enercan M, Kahraman S, Cobanoglu M, Yilar
S, Gokcen BH, Karadereler S, Mutlu A, Ulusoy LO, Ozturk C, Erturer
E, et al: Selective thoracic fusion provides similar health-related
quality of life but can cause more lumbar disc and facet joint
degeneration: A comparison of adolescent idiopathic scoliosis
patients with normal population 10 years after surgery. Spine
Deform. 3:469–475. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Canbulat N, Oktenoglu T, Ataker Y, Sasani
M, Ercelen O, Cerezci O, Suzer T and Ozer AF: A rehabilitation
protocol for patients with lumbar degenerative disc disease treated
with posterior transpedicular dynamic stabilization. Turk
Neurosurg. 27:426–435. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ji ML, Jiang H, Zhang XJ, Shi PL, Li C, Wu
H, Wu XT, Wang YT, Wang C and Lu J: Preclinical development of a
microRNA-based therapy for intervertebral disc degeneration. Nat
Commun. 9(5051)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lv K: Expression profiles of miRNAs in
polarized macrophages. Int J Mol Med. 31:797–802. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen X, Slack FJ and Zhao H: Joint
analysis of expression profiles from multiple cancers improves the
identification of microRNA-gene interactions. Bioinformatics.
29:2137–2145. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wei Y, Nazari-Jahantigh M, Chan L, Zhu M,
Heyll K, Corbalán-Campos J, Hartmann P, Thiemann A, Weber C and
Schober A: The microRNA-342-5p fosters inflammatory macrophage
activation through an akt1- and microRNA-155-depend-ent pathway
during atherosclerosis. Circulation. 127:1609–1619. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ono K, Kuwabara Y and Han J: MicroRNAs and
cardiovascular diseases. FEBS J. 278:1619–1633. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ro S, Park C, Young D, Sanders KM and Yan
W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res.
35:5944–5953. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mallory AC and Vaucheret H: MicroRNAs:
Something important between the genes. Curr Opin Plant Biol.
7:120–125. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xu JY, Yang LL, Ma C, Huang YL, Zhu GX and
Chen QL: MiR-25-3p attenuates the proliferation of tongue squamous
cell carcinoma cell line Tca8113. Asian Pac J Trop Med. 6:743–747.
2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lv F, Huang Y, Lv W, Yang L, Li F, Fan J
and Sun J: MicroRNA-146a ameliorates inflammation via TRAF6/NF-κB
pathway in intervertebral disc cells. Med Sci Monit. 23:659–664.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu W, Xia P, Feng J, Kang L, Huang M,
Wang K, Song Y, Li S, Wu X, Yang S and Yang C: MicroRNA-132
upregulation promotes matrix degradation in intervertebral disc
degeneration. Exp Cell Res. 359:39–49. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang WJ, Yang W, Ouyang ZH, Xue JB, Li XL,
Zhang J, He WS, Chen WK, Yan YG and Wang C: MiR-21 promotes ECM
degradation through inhibiting autophagy via the PTEN/akt/mTOR
signaling pathway in human degenerated NP cells. Biomed
Pharmacother. 99:725–734. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jiang R, Zhang C, Gu R and Wu H:
MicroRNA-489-3p inhibits neurite growth by regulating PI3K/AKT
pathway in spinal cord injury. Pharmazie. 72:272–278.
2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu Q, Han L, Yan W, Ji X, Han R, Yang J,
Yuan J and Ni C: miR-489 inhibits silica-induced pulmonary fibrosis
by targeting MyD88 and Smad3 and is negatively regulated by lncRNA
CHRF. Sci Rep. 6(30921)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wiese CB, Zhong JY, Xu ZQ, Zhang Y,
Ramirez Solano MA, Zhu W, Linton MF, Sheng Q, Kon V and Vickers KC:
Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces
renal injury-associated atherosclerosis. Atherosclerosis.
282:121–131. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G
and Liu J: The role of leptin on the organization and expression of
cytoskeleton elements in nucleus pulposus cells. J Orthop Res.
31:847–857. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li Z, Liang J, Wu WK, Yu X, Yu J, Weng X
and Shen J: Leptin activates RhoA/ROCK pathway to induce
cytoskeleton remodeling in nucleus pulposus cells. Int J Mol Sci.
15:1176–1188. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ding F, Shao ZW and Xiong LM: Cell death
in intervertebral disc degeneration. Apoptosis. 18:777–785.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Risbud MV and Shapiro IM: Role of
cytokines in intervertebral disc degeneration: Pain and disc
content. Nat Rev Rheumatol. 10:44–56. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cildir G, Low KC and Tergaonkar V:
Noncanonical NF-κB signaling in health and disease. Trends Mol Med.
22:414–429. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Juniper M, Le TK and Mladsi D: The
epidemiology, economic burden, and pharmacological treatment of
chronic low back pain in France, Germany, Italy, Spain and the UK:
A literature-based review. Expert Opin Pharmacother. 10:2581–2592.
2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Phillips C, Main C, Buck R, Aylward M,
Wynne-Jones G and Farr A: Prioritising pain in policy making: The
need for a whole systems perspective. Health Policy. 88:166–175.
2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Waddell G: Low back pain: A twentieth
century health care enigma. Spine (Phila Pa 1976).
21(2820)1996.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang YG, Sun Z, Zhang Z, Liu J and Guo X:
Risk factors for lumbar intervertebral disc herniation in Chinese
population: A case-control study. Spine (Phila Pa 1976).
34:918–922. 2009.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Madera M, Brady J, Deily S, McGinty T,
Moroz L, Singh D, Tipton G and Truumees E: for the Seton Spine
Rehabilitation Study Group. The role of physical therapy and
rehabilitation after lumbar fusion surgery for degenerative
disease: A systematic review. J Neurosurg Spine. 26:694–704.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis
D, Jia LT, Wu SX, Huang J, Chen J and Luo ZJ: Deregulated mir-155
promotes Fas-mediated apoptosis in human intervertebral disc
degeneration by targeting FAdd and caspase-3. J Pathol.
225:232–242. 2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ji ML, Lu J, Shi PL, Zhang XJ, Wang SZ,
Chang Q, Chen H and Wang C: Dysregulated mir-98 contributes to
extracellular matrix degradation by targeting IL-6/StAt3 signaling
pathway in human intervertebral disc degeneration. J Bone Miner
Res. 31:900–909. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X
and Qiu G: MicroRNA-10b promotes nucleus pulposus cell
proliferation through RhoC-Akt pathway by targeting HOXD10 in
intervetebral disc degeneration. PLoS One. 8(e83080)2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu H, Huang X, Liu X, Xiao S, Zhang Y,
Xiang T, Shen X, Wang G and Sheng B: miR-21 promotes human nucleus
pulposus cell proliferation through PTEN/AKT signaling. Int J Mol
Sci. 15:4007–4018. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu G, Cao P, Chen H, Yuan W, Wang J and
Tang X: MiR-27a regulates apoptosis in nucleus pulposus cells by
targeting PI3K. PLoS One. 8(e75251)2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cheng X, Zhang L, Zhang K, Zhang G, Hu Y,
Sun X, Zhao C, Li H, Li YM and Zhao J: Circular RNA VMA21 protects
against intervertebral disc degeneration through targeting miR-200c
and X linked inhibitor-of-apoptosis protein. Ann Rheum Dis.
77:770–779. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhang H, Li L, Yuan C, Wang C, Gao T and
Zheng Z: MiR-489 inhibited the development of gastric cancer via
regulating HDAC7 and PI3K/AKT pathway. World J Surg Oncol.
18(73)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Li F: Expression of miR-221 and miR-489 in
breast cancer patients and their relationship with prognosis. Oncol
Lett. 19:1523–1529. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sun D, Yu M, Huang ZH, et al: Research
progress in the action mechanism of miR-489 in tumors. Chem Life.
37:329–335. 2017.
|
|
46
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Yang YZ, Zhang YF, Yang L, Xu J, Mo XM and
Peng W: MiR-760 mediates hypoxia-induced proliferation and
apoptosis of human pulmonary artery smooth muscle cells via
targeting TLR4. Int J Mol Med. 42:2437–2446. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wang YC, Lin S and Yang QW: Toll-like
receptors in cerebral ischemic inflammatory injury. J
Neuroinflammation. 8(134)2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Li WT and Zhang Q: MicroRNA-708-5p
regulates mycobacterial vitality and the secretion of inflammatory
factors in Mycobacterium tuberculosis-infected macrophages by
targeting TLR4. Eur Rev Med Pharmacol Sci. 23:8028–8038.
2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yang J, Chen Y, Jiang K, Yang Y, Zhao G,
Guo S and Deng G: MicroRNA-106a provides negative feedback
regulation in lipopolysaccharide-induced inflammation by targeting
TLR4. Int J Biol Sci. 15:2308–2319. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Gong XY and Zhang Y: Protective effect of
miR-20a against hypoxia/reoxygenation treatment on cardiomyocytes
cell viability and cell apoptosis by targeting TLR4 and inhibiting
p38 MAPK/JNK signaling. In Vitro Cell Dev Biol Anim. 55:793–800.
2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wu D, Zheng C, Wu J, Huang R, Chen X,
Zhang T and Zhang L: Molecular biological effects of weightlessness
and hypergravity on intervertebral disc degeneration. Aerosp Med
Hum Perform. 88(1123)2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wang J, Liew OJ, Richards AM and Chen YT:
Overview of MicroRNAs in cardiac hypertrophy, fibrosis, and
apoptosis. Int J Mol Sci. 17(749)2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Moro A, Driscoll TP, Boraas LC, Armero W,
Kasper DM, Baeyens N, Jouy C, Mallikarjun V, Swift J, Ahn SJ, et
al: MicroRNA-dependent regulation of biomechanical genes
establishes tissue stiffness homeostasis. Nat Cell Biol.
21:348–358. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Toyono T, Usui T, Villarreal G Jr, Kallay
L, Matthaei M, Vianna LM, Zhu AY, Kuroda M, Amano S and Jun AS:
MicroRNA-29b overexpression decreases extracellular matrix mRNA and
protein production in human corneal endothelial cells. Cornea.
35:1466–1470. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhou J, Sun J, Markova DZ, Li S, Kepler
CK, Hong J, Huang Y, Chen W, Xu K, Wei F and Ye W: MicroRNA-145
overexpression attenuates apoptosis and increases matrix synthesis
in nucleus pulposus cells. Life Sci. 221:274–283. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Sun JC, Zheng B, Sun RX, Meng YK, Wang SM,
Yang HS, Chen Y, Shi JG and Guo YF: MiR-499a-5p suppresses
apoptosis of human nucleus pulposus cells and degradation of their
extracellular matrix by targeting SOX4. Biomed Pharmacother.
113(108652)2019.PubMed/NCBI View Article : Google Scholar
|
